ORM2 and neoplasm: CMTM7 and ORM2 as IRGs, CMTM7 acts as a tumor suppressor by inhibiting cell cycle progression in liver cancer (13), and ORM2 is closely associated with cancer-promoting pathways for liver cancer (14).